HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 208 filers reported holding HAEMONETICS CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,288,000 | -53.2% | 37,688 | -46.5% | 0.96% | +31.2% |
| Q1 2020 | $7,022,000 | +254.6% | 70,464 | +307.8% | 0.73% | +416.9% |
| Q3 2018 | $1,980,000 | +25.6% | 17,278 | -1.8% | 0.14% | +24.6% |
| Q2 2018 | $1,577,000 | +22.5% | 17,586 | 0.0% | 0.11% | +17.5% |
| Q1 2018 | $1,287,000 | -89.7% | 17,586 | -91.8% | 0.10% | -89.5% |
| Q4 2017 | $12,531,000 | +911.4% | 215,757 | +681.2% | 0.92% | +995.2% |
| Q3 2017 | $1,239,000 | -79.0% | 27,619 | -81.1% | 0.08% | -79.3% |
| Q4 2016 | $5,888,000 | -33.0% | 146,483 | -39.6% | 0.41% | -35.9% |
| Q3 2016 | $8,784,000 | -13.6% | 242,592 | -30.8% | 0.63% | -10.1% |
| Q2 2016 | $10,162,000 | +63.7% | 350,563 | +97.5% | 0.70% | +70.0% |
| Q1 2016 | $6,209,000 | +233.8% | 177,525 | +207.7% | 0.41% | +209.0% |
| Q4 2015 | $1,860,000 | – | 57,703 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |